Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Medlive Technology Co., Ltd. ( (HK:2192) ) has provided an update.
Medlive Technology Co., Ltd. has proposed a final ordinary dividend of RMB 0.1435 per share for the financial year ended 31 December 2025, equivalent to HKD 0.1629 per share based on an exchange rate of RMB 1 to HKD 1.1352. The payout, subject to shareholder approval on 15 May 2026, will see shares trade ex-dividend on 19 May 2026, with a record date of 26 May 2026 and payment scheduled for 12 June 2026, signaling continued capital returns to investors and a stable cash distribution policy.
The company’s Hong Kong share register, managed by Tricor Investor Services, will close from 21 May 2026 to 26 May 2026 for determining dividend entitlements, and no withholding tax is indicated on the declared dividend. The announcement, supported by a diversified board comprising executive, non-executive and independent non-executive directors, underlines Medlive Technology’s governance structure as it executes its shareholder return strategy.
The most recent analyst rating on (HK:2192) stock is a Buy with a HK$11.00 price target. To see the full list of analyst forecasts on Medlive Technology Co., Ltd. stock, see the HK:2192 Stock Forecast page.
More about Medlive Technology Co., Ltd.
Medlive Technology Co., Ltd. is a Hong Kong-listed company, identified by stock code 02192, operating in the technology sector and serving the healthcare and medical market. The company provides digital and technology-enabled solutions, and its shares are traded in Hong Kong dollars with corporate actions processed through Tricor Investor Services as its share registrar.
Average Trading Volume: 4,351,344
Technical Sentiment Signal: Sell
Current Market Cap: HK$5.87B
For a thorough assessment of 2192 stock, go to TipRanks’ Stock Analysis page.